Lv1
30 积分 2021-09-23 加入
DX‐8951f: Summary of Phase I Clinical Trials
11天前
已完结
Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry
1个月前
已完结
Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry
1个月前
已完结
A simultaneous analysis of the time-course of leukocytes and neutrophils following docetaxel administration using a semi-mechanistic myelosuppression model
1个月前
已完结
Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs
2个月前
已完结
Physiologically Based Pharmacokinetic Modeling to Supplement Nilotinib Pharmacokinetics and Confirm Dose Selection in Pediatric Patients
2个月前
已完结
Population Pharmacokinetics of Brentuximab Vedotin in Adult and Pediatric Patients With Relapsed/Refractory Hematologic Malignancies: Model‐Informed Hypothesis Generation for Pediatric Dosing Regimens
2个月前
已完结
A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population
2个月前
已完结
On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach
4个月前
已完结
A Quantitative Framework to Evaluate Proarrhythmic Risk in a First‐in‐Human Study to Support Waiver of a Thorough QT Study
6个月前
已完结
皖公网安备34019202002308
